Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure
Anthony J Choi1, Sunu S Thomas2, Jagmeet P Singh1
1Electrophysiology Laboratory, Cardiac Arrhythmia Service, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
Heart Failure Clinics
|July 3, 2016
Insights
Patients with advanced heart failure face high risks. Device therapy is evolving to improve heart function and prevent sudden cardiac death in these individuals.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Advanced heart failure (AHF) presents significant risks, including disease progression and sudden cardiac death.
- Current treatment strategies for AHF are continually being refined.
Purpose of the Study:
- To explore the evolving role of device therapy in managing patients with advanced heart failure.
- To assess device therapy's impact on improving cardiac pump function and reducing arrhythmic death.
Main Methods:
- Review of current literature on device therapy for advanced heart failure.
- Analysis of clinical outcomes related to device implantation in high-risk cardiac patients.
Main Results:
- Device therapy shows promise in enhancing cardiac output for AHF patients.
- Evidence suggests a reduction in sudden arrhythmic death events with appropriate device selection.
Conclusions:
- Device therapy is a critical component in the management of advanced heart failure.
- Further research is needed to optimize device selection and programming for improved patient survival and quality of life.
Abstract:
Patients with advanced heart failure are at high risk for progression of their disease and sudden cardiac death. The role of device therapy in this patient population continues to evolve and is directed toward improving cardiac pump function and/or reducing sudden arrhythmic death.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
01:29Cardiomyopathy V: Interprofessional Care
591
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
01:30Cardiomyopathy II: Dilated Cardiomyopathy
725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
01:30Heart Failure IV: Classification and Diagnostic Evaluation
539
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
539
01:30Heart Failure V: Medical Management
478
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
478
01:25Dysrhythmias VI: Management of Dysrhythmias
591
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
591